INVO Fertility, Inc.
IVF- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001417926
No open-market purchases or sales by INVO Fertility, Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $248.7K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by INVO Fertility, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for INVO Fertility, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Szot Matthew K | Director | 0 | Dec 5, 2025 | 1 |
| Shum Steve | Chief Executive Officer | 128,420 | Oct 3, 2025 | 1 |
| Davis Trent D | Director | 33,622 | Aug 28, 2025 | 0 |
| Goren Andrea | Chief Financial Officer | 129,015Indirect | Aug 28, 2025 | 0 |
| Ryan Barbara | Director | 22,991 | Aug 28, 2025 | 0 |
| Messina Rebecca | Director | 23,045 | Aug 28, 2025 | 0 |
| Campbell Michael Jos. | Chief Operating Officer | 75,762 | May 22, 2023 | 0 |
| Doody Kevin | Medical Director | 0 | Jun 3, 2022 | 0 |
| Segal Jeffrey | Director | 28,220 | Jun 3, 2022 | 0 |
| AWM Investment Company, Inc. | 10% Owner | – | Oct 12, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2025 (view filing) | Dec 3 | 2 days | Szot Matthew KDirector | SSale | −4 | $1.52 | −$6.08 | −57.1%3 after | |
| Jun 3, 2022 (view filing) | Jun 1 | 2 days | Shum SteveChief Executive Officer | PPurchase | +58.9K | $0.95 | +$55.9K | +84.7%128.4K after | |
| Jun 3, 2022 (view filing) | Jun 1 | 2 days | Ryan BarbaraDirector | PPurchase | +10.5K | $0.95 | +$10.0K | +84.4%23.0K after | |
| Jun 3, 2022 (view filing) | Jun 1 | 2 days | Davis Trent DDirector | PPurchase | +11.2K | $0.95 | +$10.6K | +49.8%33.6K after | |
| Jun 3, 2022 (view filing) | Jun 1 | 2 days | Szot Matthew KDirector | PPurchase | +14.5K | $0.95 | +$13.8K | +58.6%39.2K after | |
| Jun 3, 2022 (view filing) | Jun 1 | 2 days | Segal JeffreyDirector | PPurchase | +9.21K | $0.95 | +$8.75K | +48.5%28.2K after | |
| Jun 3, 2022 (view filing) | Jun 1 | 2 days | Campbell Michael Jos.Chief Operating Officer | PPurchase | +10.5K | $0.95 | +$10.0K | +16.1%75.8K after | |
| Jun 3, 2022 (view filing) | Jun 1 | 2 days | Goren AndreaChief Financial Officer | PPurchase | +52.6K | $0.95 | +$50.0K | +68.9%129.0K after | |
| Jun 3, 2022 (view filing) | Jun 1 | 2 days | Messina RebeccaDirector | PPurchase | +9.87K | $0.95 | +$9.37K | +74.9%23.0K after | |
| Jun 3, 2022 (view filing) | Jun 1 | 2 days | Doody KevinMedical Director | PPurchase | −177.3K | $0.95 | −$168.4K | −100.0%0 after | |
| Oct 7, 2021 (view filing) | Oct 5 | 2 days | Goren AndreaChief Financial Officer | PPurchase | +30.7K | $3.26 | +$100.0K | +67.1%76.4K after | |
| Oct 7, 2021 (view filing) | Oct 5 | 2 days | Shum SteveChief Executive Officer | PPurchase | +30.7K | $3.26 | +$100.0K | +98.2%61.9K after |